Virax Biolabs VRAX
NASDAQ VRAX
$1.34 -0.03 (-1.89%)
As of: Oct 21, 2026 · 2:35 PM EDT

Virax Biolabs (VRAX) Receivables - Net (2021 - 2025)

Updated

Virax Biolabs' Receivables - Net was $729.00 in fiscal Q2 2026 (quarter ended Sep 30, 2025), down 69.1% from $2,361 a year earlier.

Analysis

Virax Biolabs (VRAX) Receivables - Net (2021 - 2025) Analysis & Trends

At the end of FY2021 (ended Mar 31, 2021), Receivables - Net at Virax Biolabs came in at $928.00.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.84 Bn 236.87 Bn 4.88 Bn
2 Abbott Laboratories 172.03 Bn 142.46 Bn 7.27 Bn
3 Danaher 163.78 Bn 147.59 Bn 3.61 Bn
4 Intuitive Surgical 152.26 Bn 131.68 Bn 1.96 Bn
5 Medtronic 119.57 Bn 84.82 Bn 6.34 Bn
6 Stryker 114.03 Bn 100.15 Bn 4.50 Bn
7 Boston Scientific 65.44 Bn 60.21 Bn 3.85 Bn
8 Becton Dickinson 53.62 Bn 50.77 Bn 2.32 Bn
9 Edwards Lifesciences 50.94 Bn 34.94 Bn 1.35 Bn
10 Virax Biolabs 532,770.61 -20.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 729.00
Sep 30, 2024 2,361.00
Mar 31, 2021 928.00
API Access

Virax Biolabs Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=VRAX&period=max&api_key=YOUR_API_KEY